Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Zevalin Market Report 2025

Zevalin Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Relapsed Or Refractory Low-Grade Non-Hodgkin Lymphoma (NHL), Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)), By Formulation (In-111 Zevalin, Y-90 Zevalin), By Distribution Channel (Hospitals, Specialty Pharmacies, Online Pharmacies), By End-User (Adult Patients, Geriatric Patients)

Zevalin Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Zevalin Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Zevalin Market Definition

Zevalin (ibritumomab tiuxetan) is a monoclonal antibody used to treat non-Hodgkin lymphoma. It is a radiolabeled therapy that combines an antibody with yttrium-90, a radioactive substance, to target and destroy cancer cells. This targeted radiation helps slow lymphoma growth while minimizing harm to healthy tissues.

The main types of indication for zevalin are relapsed or refractory low-grade non-Hodgkin lymphoma (NHL) and previously untreated follicular non-Hodgkin lymphoma (NHL). Relapsed or refractory low-grade non-Hodgkin lymphoma (NHL) refers to NHL that has either recurred after initial therapy (relapsed) or is resistant to further treatment (refractory). It is formulated in various formulations, such as in-111 Zevalin and Y-90 Zevalin, and it is distributed through several distribution channels, including hospitals, specialty pharmacies, and online pharmacies. It is used by various end users, such as adult patients and geriatric patients.

Zevalin Market Segmentation

The zevalin market covered in this report is segmented –

1) By Indication: Relapsed Or Refractory Low-Grade Non-Hodgkin Lymphoma (NHL); Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)

2) By Formulation: In-111 Zevalin; Y-90 Zevalin

3) By Distribution Channel: Hospitals; Specialty Pharmacies; Online Pharmacies

4) By End-User: Adult Patients; Geriatric Patients

Zevalin Market Size and growth rate 2025 to 2029: Graph

Zevalin Market Size 2025 And Growth Rate

The zevalin market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising incidence of non-hodgkin lymphoma, increasing demand for personalized medicine, rising healthcare expenditure, rising prevalence of relapsed or refractory lymphoma cases, and increasing adoption of radioimmunotherapy.

Zevalin Market Growth Forecast

The zevalin market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising prevalence of cancers, growth in healthcare infrastructure, increasing emphasis on early diagnosis, rising demand for outpatient treatment options, and increasing government support for cancer treatment initiatives. Major trends in the forecast period include advances in radioimmunotherapy, development of more precise drug delivery systems, radiolabeled antibody development, nuclear medicine innovation, and artificial intelligence in drug discovery.

Book your 30 minutes free consultation with our research experts

Contact Us

Zevalin Market Driver: Rising Incidence Of Non-Hodgkin’s Lymphoma Drives Growth In The Market

The rising incidence of non-Hodgkin’s lymphoma is set to propel growth of the zevalin market moving forward. Non-Hodgkin lymphoma is a range of blood cancers that start in lymphocytes and impact the lymphatic system and immune system. The incidence of non-Hodgkin lymphoma is attributed to various factors, including an aging population, increased exposure to risk factors such as immunosuppression, as well as environmental influences and lifestyle changes. Zevalin is a monoclonal antibody that targets CD20, a protein on B-cells commonly affected in non-Hodgkin’s lymphoma. It delivers targeted radiation to destroy cancerous B-cells, shrinking tumors and increasing the likelihood of remission. For instance, in January 2024, according to a report published by the American Cancer Society, Inc., a US-based nonprofit organization, non-Hodgkin lymphoma is among the most prevalent cancers in the United States, representing approximately 4% of all new cancer cases. In 2024, an estimated 80,620 individuals will be diagnosed, including 44,590 males and 36,030 females. Therefore, the rising incidence of non-Hodgkin’s lymphoma is driving the growth of the zevalin market.

Zevalin Market Driver: Impact Of Growing Healthcare Infrastructure On The Market Growth

The growth in healthcare infrastructure is significantly driving the growth of the zevalin market in the future. Healthcare infrastructure involves the facilities, systems, equipment, and workforce that support the provision of healthcare services. The growth in healthcare infrastructure is driven by factors such as an aging population, rising demand for quality healthcare services, increased government investment and support, and advancements in medical technology. The expansion of healthcare infrastructure is improving access to advanced cancer treatments, making zevalin more vital in treating cancer, and its targeted radioimmunotherapy enhances patient outcomes in a stronger healthcare system. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, the growth in healthcare infrastructure is driving the growth of the zevalin market.

Zevalin Market Driver: Rising Geriatric Population Driving Growth In The Market

Growth in the geriatric population is expected to propel the growth of the zevalin market going forward. The geriatric population consists of individuals aged 65 and older, who typically need specialized medical care due to age-related health challenges. The growth in the geriatric population is primarily driven by increased life expectancy, declining fertility rates, and improved healthcare access. Zevalin offers a targeted, less invasive treatment option, making it ideal for older patients with underlying health conditions. It minimizes side effects and enhances outcomes, improving their quality of life. For instance, in July 2024, according to the House of Commons Library, a UK-based government agency, there are approximately 33 individuals aged 65 and over for every 100 people aged 20 to 64 in the UK, and in 2022 this amounted to around 12.7 million people aged 65 or older, representing 19% of the population, with projections indicating a rise to 22.1 million, or 27% of the population, by 2072. Therefore, the growth in the geriatric population is driving the growth of the zevalin market.

Global Zevalin Market Major Players

Major companies operating in the zevalin market are Acrotech Biopharma Inc.

Regional Analysis For The Global Zevalin Market

North America was the largest region in the zevalin market in 2024. The regions covered in the zevalin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zevalin market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zevalin Market?

The zevalin market consists of sales of injections, radiolabeled therapy kits, and diagnostic kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zevalin Industry?

The zevalin market research report is one of a series of new reports from The Business Research Company that provides zevalin market statistics, including the zevalin industry global market size, regional shares, competitors with the zevalin market share, detailed zevalin market segments, market trends, and opportunities, and any further data you may need to thrive in the zevalin industry. This zevalin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Zevalin Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The zevalin market covered in this report is segmented –
1) By Indication: Relapsed Or Refractory Low-Grade Non-Hodgkin Lymphoma (NHL); Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)
2) By Formulation: In-111 Zevalin; Y-90 Zevalin
3) By Distribution Channel: Hospitals; Specialty Pharmacies; Online Pharmacies
4) By End-User: Adult Patients; Geriatric Patients
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Acrotech Biopharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Zevalin Market Characteristics

    3. Zevalin Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Zevalin Market Trends And Strategies

    5. Zevalin Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Zevalin Growth Analysis And Strategic Analysis Framework

    6.1. Global Zevalin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Zevalin Market Growth Rate Analysis

    6.4. Global Zevalin Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Zevalin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Zevalin Total Addressable Market (TAM)

    7. Global Zevalin Pricing Analysis & Forecasts

    8. Zevalin Market Segmentation

    8.1. Global Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Relapsed Or Refractory Low-Grade Non-Hodgkin Lymphoma (NHL)

    Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)

    8.2. Global Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    In-111 Zevalin

    Y-90 Zevalin

    8.3. Global Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Pharmacies

    Online Pharmacies

    8.4. Global Zevalin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult Patients

    Geriatric Patients

    9. Global Zevalin Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Zevalin Market Regional And Country Analysis

    10.1. Global Zevalin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Zevalin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Zevalin Market

    11.1. Asia-Pacific Zevalin Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Zevalin Market

    12.1. China Zevalin Market Overview

    12.2. China Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Zevalin Market

    13.1. India Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Zevalin Market

    14.1. Japan Zevalin Market Overview

    14.2. Japan Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Zevalin Market

    15.1. Australia Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Zevalin Market

    16.1. South Korea Zevalin Market Overview

    16.2. South Korea Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Zevalin Market

    17.1. Western Europe Zevalin Market Overview

    17.2. Western Europe Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Zevalin Market

    18.1. UK Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Zevalin Market

    19.1. Germany Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Zevalin Market

    20.1. France Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Zevalin Market

    21.1. Eastern Europe Zevalin Market Overview

    21.2. Eastern Europe Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Zevalin Market

    22.1. North America Zevalin Market Overview

    22.2. North America Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Zevalin Market

    23.1. USA Zevalin Market Overview

    23.2. USA Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Zevalin Market

    24.1. Canada Zevalin Market Overview

    24.2. Canada Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Zevalin Market

    25.1. South America Zevalin Market Overview

    25.2. South America Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Zevalin Market

    26.1. Middle East Zevalin Market Overview

    26.2. Middle East Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Zevalin Market

    27.1. Africa Zevalin Market Overview

    27.2. Africa Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Zevalin Market Competitive Landscape And Company Profiles

    28.1. Zevalin Market Competitive Landscape

    28.2. Zevalin Market Company Profiles

    28.2.1. Acrotech Biopharma Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Zevalin Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Zevalin Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Zevalin Market

    32. Recent Developments In The Zevalin Market

    33. Zevalin Market High Potential Countries, Segments and Strategies

    33.1 Zevalin Market In 2029 - Countries Offering Most New Opportunities

    33.2 Zevalin Market In 2029 - Segments Offering Most New Opportunities

    33.3 Zevalin Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Zevalin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Zevalin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Zevalin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Acrotech Biopharma Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Zevalin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Zevalin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Zevalin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Zevalin Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Zevalin Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Zevalin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Acrotech Biopharma Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cervical Cancer Drugs Global Market Report 2025 – By Cancer Type (Squamous Cell Cancer, Adenocarcinoma), By Drug Type (Avastin, Bevacizumab, Bleomycin, Blenoxane, Other Drug Types), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Zevalin market?

Zevalin (ibritumomab tiuxetan) is a monoclonal antibody used to treat non-Hodgkin lymphoma. It is a radiolabeled therapy that combines an antibody with yttrium-90, a radioactive substance, to target and destroy cancer cells. This targeted radiation helps slow lymphoma growth while minimizing harm to healthy tissues. For further insights on the Zevalin market, request a sample here

How will the Zevalin market drivers and restraints affect the market dynamics? What forces will shape the Zevalin industry going forward?

The Zevalin market major growth driver - Rising Incidence Of Non-Hodgkin’s Lymphoma Drives Growth In The Market. For further insights on the Zevalin market, request a sample here

What is the forecast market size or the forecast market value of the Zevalin market?

The Zevalin market size has grown strongly in recent years. The zevalin market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the rising incidence of non-hodgkin lymphoma, increasing demand for personalized medicine, rising healthcare expenditure, rising prevalence of relapsed or refractory lymphoma cases, and increasing adoption of radioimmunotherapy. The zevalin market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising prevalence of cancers, growth in healthcare infrastructure, increasing emphasis on early diagnosis, rising demand for outpatient treatment options, and increasing government support for cancer treatment initiatives. Major trends in the forecast period include advances in radioimmunotherapy, development of more precise drug delivery systems, radiolabeled antibody development, nuclear medicine innovation, and artificial intelligence in drug discovery. For further insights on the Zevalin market, request a sample here

How is the Zevalin market segmented?

The zevalin market covered in this report is segmented –
1) By Indication: Relapsed Or Refractory Low-Grade Non-Hodgkin Lymphoma (NHL); Previously Untreated Follicular Non-Hodgkin Lymphoma (NHL)
2) By Formulation: In-111 Zevalin; Y-90 Zevalin
3) By Distribution Channel: Hospitals; Specialty Pharmacies; Online Pharmacies
4) By End-User: Adult Patients; Geriatric Patients For further insights on the Zevalin market, request a sample here

Which region has the largest share of the Zevalin market? What are the other regions covered in the report?

North America was the largest region in the zevalin market in 2024. The regions covered in the zevalin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Zevalin market, request a sample here.

Who are the major players in the Zevalin market?

Major companies operating in the zevalin market are Acrotech Biopharma Inc. . For further insights on the Zevalin market, request a sample here.

What are the key trends in the Zevalin market?

Major trends in the Zevalin market include . For further insights on the Zevalin market, request a sample here.

What are the major opportunities in the Zevalin market? What are the strategies for the Zevalin market?

For detailed insights on the major opportunities and strategies in the Zevalin market, request a sample here.

How does the Zevalin market relate to the overall economy and other similar markets?

For detailed insights on Zevalin's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Zevalin industry?

For detailed insights on the mergers and acquisitions in the Zevalin industry, request a sample here.

What are the key dynamics influencing the Zevalin market growth? SWOT analysis of the Zevalin market.

For detailed insights on the key dynamics influencing the Zevalin market growth and SWOT analysis of the Zevalin industry, request a sample here.